Clinical assessment of irritable bowel syndrome

Journal of Clinical Gastroenterology

Volumn 35, Issue 1 SUPPL., 2002, Pages

  Lembo, Tony J ^a   Fink, Rebecca N ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Clinical Assessment; Diagnostic Criteria; Irritable Bowel Syndrome

Indexed keywords

ANAMNESIS; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ENTERITIS; GASTROINTESTINAL SYMPTOM; IRRITABLE COLON; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; HOSPITALIZATION; HUMAN; PROGNOSIS; REVIEW; RISK FACTOR;

COLONIC DISEASES, FUNCTIONAL; DIAGNOSIS, DIFFERENTIAL; HUMANS; PRACTICE GUIDELINES; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0036083651     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200207001-00007     Document Type: Conference Paper

References (68)

1. What are functional bowel disorders?
2. Towards positive diagnosis of the irritable bowel
3. Irritable bowel syndrome in the general population
4. Non-colonic features of irritable bowel syndrome
5. Irritable bowel syndrome symptom patterns: Frequency, duration, and severity
6. Bladder smooth muscle dysfunction in patients with irritable bowel syndrome
7. Severe sexual dysfunction in women with the irritable bowel syndrome: Comparison with inflammatory bowel disease and duodenal ulceration
8. Primary fibromyalgia and the irritable bowel syndrome: Different expressions of a common pathogenetic process
9. Subjective and objective sleep quality in irritable bowel syndrome
10. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: A prevalence study
11. Irritable bowel syndrome in general practice: Prevalence, characteristics, and referral
12. More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology
13. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction
14. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates
15. The association of irritable bowel syndrome and somatization disorder
16. Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome
17. What determines severity among patients with painful functional bowel disorders?
18. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome
19. Irritable bowel syndrome (IBS) and alcohol abuse or dependence
20. Food-related gastrointestinal symptoms in the irritable bowel syndrome
21. Diagnostic value of the Manning criteria in irritable bowel syndrome
22. Gender differences in Manning criteria in the irritable bowel syndrome
23. Evaluation of Manning's criteria in the diagnosis of irritable bowel syndrome
24. Manning criteria in irritable bowel syndrome: Its diagnostic significance
25. Prognosis in the irritable bowel syndrome: A 5-year prospective study
26. Irritable bowel syndrome - A safe diagnosis?
27. Irritable bowel syndrome - Prognosis and diagnostic safety. A 5-year follow-up study
28. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease
29. Irritable bowel syndrome. Still far from a positive diagnosis
30. Irritable bowel syndrome: Guidelines for the diagnosis
31. Identification of subgroups of functional bowel disorders
32. Functional bowel disorders and functional abdominal pain
33. Diagnostic criteria for the irritable bowel syndrome
34. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome
35. Irritable bowel syndrome: Which definitions are consistent?
36. Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms
37. Irritable bowel syndrome according to varying diagnostic criteria: Are the new Rome II criteria unnecessarily restrictive for research and practice?
38. Reclassification of functional bowel disorder with Rome II diagnostic criteria
39. How restrictive are Rome II criteria for the diagnosis of the irritable bowel syndrome (IBS)?
40. Do the Rome I and Rome II criteria identify the same IBS patients?
41. Irritable bowel syndrome: How far do you go in the workup?
42. Is rectal biopsy necessary in irritable bowel syndrome?
43. Defining and diagnosing irritable bowel syndrome
44. Fructose-sorbitol malabsorption and symptom provocation in irritable bowel syndrome: Relationship to enteric hypersensitivity and dysmotility
45. Characteristics of patients with irritable bowel syndrome recruited from three sources: Implications for clinical trials
46. Dietary treatment of irritable bowel syndrome: Current evidence and guidelines for future practice
47. Personality and psychological factors in the irritable bowel syndrome
48. Presidential address: Gastrointestinal illness and the biopsycho-social model
49. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome
50. Psychosocial aspects of the functional gastrointestinal disorders
51. Diagnostic approach to the patient with irritable bowel syndrome
52. The diagnostic sensitivity of physical signs in the irritable bowel syndrome
53. The irritable bowel syndrome: Mechanisms and a practical approach to management
54. AGA technical review on anorectal testing techniques
55. Admission stool guaiac test: Use and impact on patient management
56. Checking for 'the occult' with a finger. A procedure of little value
57. Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome
58. Confirmation of presumptive diagnosis of irritable bowel syndrome (IBS) utilizing Rome II criteria and simple laboratory screening tests with diagnostic (GI) evaluation
59. Evaluation of patients who meet clinical criteria for irritable bowel syndrome
60. Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome?
61. Abdominal pain and bowel dysfunction: Diagnostic role of intestinal ultrasound
62. AGA technical review on the evaluation and management of chronic diarrhea
63. Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth
64. AGA technical review on constipation
65. Functional bowel disorder and functional abdominal pain
66. University of Miami Division of Clinical Pharmacology therapeutic rounds: Irritable bowel syndrome: Pathophysiology, diagnosis, and treatment